Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Titan Pharmaceuticals, Inc. - Common Stock (NQ:TTNP)

5.134 +0.444 (+9.46%)
Streaming Delayed Price Updated: 3:57 PM EDT, Jul 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 85,262
Open 4.827
Bid (Size) 5.000 (1)
Ask (Size) 5.200 (10)
Prev. Close 4.690
Today's Range 4.683 - 5.350
52wk Range 3.030 - 14.80
Shares Outstanding 914,234
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga

Performance

YTD
+60.9%
+60.9%
1 Month
+16.7%
+16.7%
3 Month
+35.5%
+35.5%
6 Month
+36.0%
+36.0%
1 Year
-14.2%
-14.2%

More News

Read More
US Stocks Likely To Open Higher: Expert Says 'The Selling Pressure Is Starting To Be Exhausted'
Via Benzinga
Goldman Sachs, M&T Bank And 3 Stocks To Watch Heading Into Monday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iteris, Inc. (Nasdaq - ITI), Forza X1, Inc. (Nasdaq - FRZA), Titan Pharmaceuticals, Inc. (Nasdaq - TTNP), Gatos Silver, Inc. (NYSE - GATO)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CFB, SDIG, TTNP on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, K, TTNP on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP
From Kahn Swick & Foti, LLC
Via Business Wire
Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings
Via Benzinga
Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
Via Benzinga
US Stocks Mixed; Lowe's Cuts FY24 Forecast
Via Benzinga
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
TTNP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Titan Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q2 2024
Via InvestorPlace
TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q4 2023
Via InvestorPlace
TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is Titan Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Titan Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Titan Pharmaceuticals, Inc. - Common Stock trade on?
Titan Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Titan Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Titan Pharmaceuticals, Inc. - Common Stock is TTNP on the Nasdaq Stock Market
What is the current price of Titan Pharmaceuticals, Inc. - Common Stock?
The current price of Titan Pharmaceuticals, Inc. - Common Stock is 5.134
When was Titan Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Titan Pharmaceuticals, Inc. - Common Stock was at 07/24/25 03:57 PM ET
What is the market capitalization of Titan Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Titan Pharmaceuticals, Inc. - Common Stock is 4.69M
How many shares of Titan Pharmaceuticals, Inc. - Common Stock are outstanding?
Titan Pharmaceuticals, Inc. - Common Stock has 5M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.